ROYCE & ASSOCIATES LP - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$23,000
+35.3%
2,2620.0%0.00%
Q2 2014$17,000
-99.0%
2,262
-99.5%
0.00%
-100.0%
Q1 2014$1,645,000
-16.0%
500,000
-15.3%
0.01%
-16.7%
Q4 2013$1,959,000590,0000.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders